Published in Pediatr Endocrinol Rev on June 01, 2008
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2013) 2.43
Polycystic ovary syndrome in the pediatric population. Metab Syndr Relat Disord (2010) 0.93
Obesity differentially affects phenotypes of polycystic ovary syndrome. Int J Endocrinol (2012) 0.85
Interventional studies for polycystic ovarian syndrome in children and adolescents. Ped Health (2010) 0.81
Myo-Inositol in the Treatment of Teenagers Affected by PCOS. Int J Endocrinol (2016) 0.76
Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab (2010) 1.24
Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. Eur J Endocrinol (2009) 1.23
Metabolic syndrome and polycystic ovary syndrome... and vice versa. Arq Bras Endocrinol Metabol (2009) 1.10
Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances. Eur J Clin Invest (2012) 1.06
Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. J Clin Endocrinol Metab (2004) 0.99
Metformin in polycystic ovary syndrome. Ann N Y Acad Sci (2010) 0.98
Accumulation of dietary glycotoxins in the reproductive system of normal female rats. J Mol Med (Berl) (2007) 0.96
Assessment of thyroid function in two hundred patients with beta-thalassemia major. Thyroid (2002) 0.95
Thyroid volume and echostructure in schoolchildren living in an iodine-replete area: relation to age, pubertal stage, and body mass index. Thyroid (2007) 0.94
Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS). J Steroid Biochem Mol Biol (2008) 0.94
Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) (2008) 0.93
Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome. J Bone Miner Metab (2010) 0.93
Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism? Eur J Endocrinol (2008) 0.91
Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome. Eur J Endocrinol (2009) 0.89
Phenotypes and enviromental factors: their influence in PCOS. Curr Pharm Des (2012) 0.86
Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents? Hormones (Athens) (2007) 0.82
Endocrine pancreatic insufficiency in chronic pancreatitis. Pancreatology (2005) 0.81
Prolonged jaundice and hypothyroidism as the presenting symptoms in a neonate with a novel Prop1 gene mutation (Q83X). Eur J Endocrinol (2004) 0.81
In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls. Hormones (Athens) (2009) 0.80
Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats. J Endocrinol (2013) 0.80
Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy. Kidney Blood Press Res (2009) 0.80
Reduced ovarian glyoxalase-I activity by dietary glycotoxins and androgen excess: a causative link to polycystic ovarian syndrome. Mol Med (2012) 0.79
Endocrine and metabolic aspects of the Wolfram syndrome. Endocrine (2011) 0.78
Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome. Clin Endocrinol (Oxf) (2011) 0.78
Strong and positive association of endothelin-1 with AGEs in PCOS: a causal relationship or a bystander? Hormones (Athens) (2012) 0.77
Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (2014) 0.76
Polycystic ovary syndrome offspring display increased oxidative stress markers comparable to gestational diabetes offspring. Fertil Steril (2012) 0.76
The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers. Hormones (Athens) (2015) 0.76
The pluripotential effects of hypolipidemic treatment for polycystic ovary syndrome (PCOS): dyslipidemia, cardiovascular risk factors and beyond. Curr Pharm Des (2011) 0.76
Impact of Androgen and Dietary Advanced Glycation End Products on Female Rat Liver. Cell Physiol Biochem (2015) 0.75
Ovulation induction and successful pregnancy outcome in two patients with Prop1 gene mutations. Fertil Steril (2004) 0.75
Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects. Horm Mol Biol Clin Investig (2014) 0.75
Glucose dysregulation in obese children: predictive, risk, and potential protective factors. Obesity (Silver Spring) (2007) 0.75
White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia. Hormones (Athens) (2015) 0.75